\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ visible\\ abnormality\\ of\\ the\\ eyelid\\/puncta\\/eye\\/orbit\\;\\ no\\ visible\\ obstruction\\ in\\ the\\ nasopharynx\ \(0\)\
\-\ therapeutic\\ dilation\\ of\\ duct\ \(0\)\
\-\ mild\\ narrowing\\ in\\ the\\ region\\ of\\ the\\ valve\\ of\\ krause\ \(0\)\
\-\ nasolacrimal\\ duct\\ stenosis\\ at\\ the\\ level\\ of\\ the\\ valve\\ of\\ krause\ \(0\)\
\-\ congential\\ nasolacrimal\\ duct\\ stenosis\ \(0\)\
\-\ acquired\\ nasolacrimal\\ duct\\ stenosis\ \(0\)\
\-\ chronic\\ overflow\\ of\\ tears\\ from\\ right\\ orbit\ \(0\)\
\-\ acquired\\ nasolacrimal\\ drainage\\ obstructions\\ may\\ be\\ related\\ to\\ infection\\ \\(numerous\\ bacterial\\/viral\\/parasitic\\ causes\\)\\,\\ inflammation\\/scarring\\ \\(wegener\\'s\\ granulomatosis\\,\\ sarcoidosis\\,\\ radiation\\)\\,\\ medications\\ \\(chemotherapy\\)\\,\\ congenital\\ narrowing\\,\\ tumors\\ \\(scc\\)\\,\\ or\\ trauma\\.\\ \\ occasionally\\,\\ small\\ nasolacrimal\\ duct\\ stones\\ may\\ be\\ found\\ blocking\\ the\\ duct\\.\ \(0\)\
\-\ of\\ interest\\,\\ the\\ use\\ of\\ i\\(131\\)\\ for\\ thyroid\\ carcinoma\\ is\\ associated\\ with\\ a\\ an\\ overall\\ 4\\.6\\%\\ incidence\\ of\\ documented\\ or\\ suspected\\ obstruction\\.\\ \\ \ \(0\)\
\-\ the\\ cause\\ of\\ the\\ narrowing\\ in\\ our\\ patient\\ was\\ unknown\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nasolacrimal\\:\\ 0\\.5071579047037721\ \(0\)\
\-\ duct\\:\\ 0\\.40287206863789715\ \(0\)\
\-\ krause\\:\\ 0\\.24948505981564245\ \(0\)\
\-\ narrowing\\:\\ 0\\.1814026349517381\ \(0\)\
\-\ stenosis\\:\\ 0\\.17800450374252985\ \(0\)\
\-\ of\\:\\ 0\\.16791157984448987\ \(0\)\
\-\ the\\:\\ 0\\.1556426914926154\ \(0\)\
\-\ acquired\\:\\ 0\\.15036563341766046\ \(0\)\
\-\ orbit\\:\\ 0\\.14448271099021642\ \(0\)\
\-\ valve\\:\\ 0\\.14305053758763547\ \(0\)\
\-\ visible\\:\\ 0\\.1375118508962823\ \(0\)\
\-\ overflow\\:\\ 0\\.12474252990782123\ \(0\)\
\-\ obstruction\\:\\ 0\\.10927227627891058\ \(0\)\
\-\ blocking\\:\\ 0\\.10761208479432564\ \(0\)\
\-\ obstructions\\:\\ 0\\.10578615902080891\ \(0\)\
\-\ congential\\:\\ 0\\.10143158094075441\ \(0\)\
\-\ interest\\:\\ 0\\.09719048177865962\ \(0\)\
\-\ scc\\:\\ 0\\.0954789845485161\ \(0\)\
\-\ nasopharynx\\:\\ 0\\.09325667939448569\ \(0\)\
\-\ wegener\\:\\ 0\\.0872639239979466\ \(0\)\
\-\ granulomatosis\\:\\ 0\\.08600079910500995\ \(0\)\
\-\ documented\\:\\ 0\\.08344084392832904\ \(0\)\
\-\ tears\\:\\ 0\\.0824752100537421\ \(0\)\
\-\ 131\\:\\ 0\\.0824752100537421\ \(0\)\
\-\ therapeutic\\:\\ 0\\.07893550212549871\ \(0\)\
\-\ may\\:\\ 0\\.0785063527198329\ \(0\)\
\-\ occasionally\\:\\ 0\\.07482295038375267\ \(0\)\
\-\ stones\\:\\ 0\\.07363314540447494\ \(0\)\
\-\ overall\\:\\ 0\\.0716655175221\ \(0\)\
\-\ our\\:\\ 0\\.0691021244745937\ \(0\)\
\-\ dilation\\:\\ 0\\.06864244653018144\ \(0\)\
\-\ incidence\\:\\ 0\\.06714534477298287\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.06607422487598771\ \(0\)\
\-\ numerous\\:\\ 0\\.0658881794055866\ \(0\)\
\-\ medications\\:\\ 0\\.06543384754283933\ \(0\)\
\-\ suspected\\:\\ 0\\.06391293362266032\ \(0\)\
\-\ be\\:\\ 0\\.06328476408020231\ \(0\)\
\-\ drainage\\:\\ 0\\.062472220115001545\ \(0\)\
\-\ thyroid\\:\\ 0\\.06130041926095281\ \(0\)\
\-\ use\\:\\ 0\\.05968250071004237\ \(0\)\
\-\ related\\:\\ 0\\.059277740004634996\ \(0\)\
\-\ unknown\\:\\ 0\\.059107872837135485\ \(0\)\
\-\ causes\\:\\ 0\\.05894008998198449\ \(0\)\
\-\ in\\:\\ 0\\.05821326206007962\ \(0\)\
\-\ tumors\\:\\ 0\\.05736661687677887\ \(0\)\
\-\ abnormality\\:\\ 0\\.0567372537457048\ \(0\)\
\-\ congenital\\:\\ 0\\.05604532885431245\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.0553867361879067\ \(0\)\
\-\ or\\:\\ 0\\.05427116636430238\ \(0\)\
\-\ cause\\:\\ 0\\.05313873582217634\ \(0\)\
\-\ radiation\\:\\ 0\\.05169075077425794\ \(0\)\
\-\ no\\:\\ 0\\.0507308683473713\ \(0\)\
\-\ found\\:\\ 0\\.050470991497928566\ \(0\)\
\-\ level\\:\\ 0\\.04711785398897541\ \(0\)\
\-\ infection\\:\\ 0\\.04711785398897541\ \(0\)\
\-\ region\\:\\ 0\\.04665740202983812\ \(0\)\
\-\ carcinoma\\:\\ 0\\.04665740202983812\ \(0\)\
\-\ chronic\\:\\ 0\\.04629988804110489\ \(0\)\
\-\ trauma\\:\\ 0\\.04530071151378185\ \(0\)\
\-\ mild\\:\\ 0\\.044217240461840626\ \(0\)\
\-\ associated\\:\\ 0\\.04111301897050589\ \(0\)\
\-\ small\\:\\ 0\\.04023617176328327\ \(0\)\
\-\ from\\:\\ 0\\.03097917458380151\ \(0\)\
\-\ an\\:\\ 0\\.029827786855109523\ \(0\)\
\-\ at\\:\\ 0\\.029462425738834223\ \(0\)\
\-\ was\\:\\ 0\\.02718454570919024\ \(0\)\
\-\ right\\:\\ 0\\.025860963128793157\ \(0\)\
\-\ patient\\:\\ 0\\.025370206161567255\ \(0\)\
\-\ for\\:\\ 0\\.02364187404947463\ \(0\)\
\-\ is\\:\\ 0\\.02136143772254806\ \(0\)\
\-\ to\\:\\ 0\\.019500401623095364\ \(0\)\
\-\ with\\:\\ 0\\.015273809724857803\ \(0\)\
